483
Solvias AGFDA 483 - Solvias AG - November 22, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Solvias AG, a control testing laboratory in Kaiseraugst, Switzerland, revealed significant deficiencies in their quality system. Observations included a failure to thoroughly investigate out-of-specification results and equipment malfunctions, as well as inadequate calibration and mapping of stability chambers and sensors. These issues raise concerns about the reliability of testing data for U.S. drug products.
Open in Dashboard
ID · d52e4437-b051-4603-9491-065d33b20e4f